Position in MRNA
as of Mar 31, 2026
· filed Apr 29, 2026
Position Value
$1,378,864
+$104,602 QoQ
Shares Held
27,143
-37.2% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
17 quarters on record
Common Shares in MRNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MEITAV INVESTMENT HOUSE LTD holds $8,599,446 across 5 Biotechnology names. MRNA ranks #2 (16.0% of the industry book) .
All Filings in MRNA
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,378,864 | 27,143 | Shares | Defined | 2026-04-29 | |
| 2025-12-31 | $1,274,262 | 43,210 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $1,116,114 | 43,210 | Shares | Defined | 2025-10-29 | |
| 2025-06-30 | $1,192,163 | 43,210 | Shares | Defined | 2025-07-23 | |
| 2025-03-31 | $1,225,003 | 43,210 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $1,782,118 | 42,860 | Shares | Defined | 2025-02-03 | |
| 2024-09-30 | $15,163,927 | 226,903 | Shares | Defined | 2024-10-28 | |
| 2024-06-30 | $13,707,075 | 115,428 | Shares | Defined | 2024-07-29 | |
| 2024-03-31 | $17,838,783 | 167,406 | Shares | Defined | 2024-05-01 | |
| 2023-12-31 | $16,638,979 | 167,310 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $17,279,797 | 167,294 | Shares | Defined | 2023-10-30 | |
| 2023-06-30 | $18,845,257 | 155,105 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $23,821,025 | 155,105 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $4,103,598 | 22,846 | Shares | Defined | 2023-02-06 | |
| 2022-09-30 | $2,701,539 | 22,846 | Shares | Defined | 2022-10-31 | |
| 2022-06-30 | $3,254,265 | 22,781 | Shares | Defined | 2022-08-01 | |
| 2022-03-31 | $2,573,908 | 14,942 | Shares | Defined | 2022-05-09 | |
| No filing history on record for this holder in this stock. | ||||||